Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immunosuppression and transplantation have been reported to induce
porokeratosis
(PK), especially its variant, disseminated superficial PK (DSP). On the other hand, there is ample evidence of a relationship between hepatitis C virus (HCV) infection, liver cirrhosis (LC), and
hepatocellular carcinoma
(
HCC
). We report 3 cases of DSP in which the outbreak of DSP was suspected to have occurred during the development of
HCC
in patients with HCV-positive LC. The patients had undergone ultrasonographic study regularly, and no signs of malignancy had been found before the development of DSP. Their outbreaks of DSP were very acute, and the period between the development of DSP and diagnosis of
HCC
ranged from 2 to 6 months. The association of HCV-related
HCC
and DSP has never been previously reported. HCV-induced immunomodulation or its effect on the p53 system may be the basis for this type of association. It is necessary to consider development of
HCC
whenever DSP is found in HCV-positive patients. DSP may be a new paraneoplastic dermadrome.
...
PMID:Synchronous development of disseminated superficial porokeratosis and hepatitis C virus-related hepatocellular carcinoma. 1104 35
Disseminated superficial porokeratosis has been described in the setting of immunosuppressive conditions, including organ transplantation, infections, and hematopoietic malignancies. The outbreak of disseminated superficial
porokeratosis
during the development of solid organ malignancies has been rarely reported in the literature in patients affected by hepatitis C virus-related
hepatocellular carcinoma
or by cholangiocarcinoma, which suggests a paraneoplastic nature of the cutaneous disease. We report an unusual case of disseminated superficial
porokeratosis
in a patient affected by ovarian cancer, characterized by simultaneous onset and a parallel course of the two pathologies; there was good clinical response to chemotherapy, accompanied by a successful stop of disseminated superficial
porokeratosis
progression and gradual clearing of the keratotic lesions.
...
PMID:Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? 1825 33